Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
A reverse mortgage allows homeowners to cash in on the value they've poured into their homes. Unlike home equity loans or HELOCs, however, they don't have to make payments until they move out or pass ...
© 2026 Forbes Media LLC. All Rights Reserved.
© 2026 Forbes Media LLC. All Rights Reserved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results